​

Definitive Healthcare (DH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DH Stock Forecast

Definitive Healthcare (DH) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $3.13, with a high of $3.50 and a low of $2.75. This represents a 160.83% increase from the last price of $1.20.

$1 $2 $3 $4 $5 $6 $7 $8 $9 $10 High: $3.5 Avg: $3.13 Low: $2.75 Last Closed Price: $1.2

DH Stock Rating

Definitive Healthcare stock's rating consensus is Hold, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (20.00%), 10 Hold (66.67%), 2 Sell (13.33%), and 0 Strong Sell (0.00%).

Hold
Total 15 0 2 10 3 Strong Sell Sell Hold Buy Strong Buy

DH Price Target Upside V Benchmarks

TypeNameUpside
StockDefinitive Healthcare160.83%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 45.44%

Price Target Trends

1M3M12M
# Anlaysts-13
Avg Price Target-$3.50$3.42
Last Closing Price$1.20$1.20$1.20
Upside/Downside-191.67%185.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26-38-112
Feb, 26-38-112
Jan, 26-39-113
Dec, 25-39-113
Nov, 25-39-113
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 18, 2025Craig HettenbachMorgan Stanley$3.50$2.2853.51%191.67%
Dec 08, 2025Barclays$2.75$2.4512.24%129.17%
Aug 08, 2025Joe VruwinkRobert W. Baird$4.00$3.863.63%233.33%
Sep 17, 2024David LarsenBTIG$7.00$4.4457.66%483.33%
Aug 09, 2024George HillDeutsche Bank$5.00$3.8729.20%316.67%
Aug 07, 2024Saket KaliaBarclays$4.00$3.659.59%233.33%
Aug 06, 2024Craig HettenbachMorgan Stanley$5.00$3.7234.41%316.67%
Aug 05, 2024Kash RanganGoldman Sachs$8.00$3.55125.35%566.67%
Jul 31, 2024David GrossmanStifel Nicolaus$7.50$3.41119.94%525.00%
May 09, 2024Saket KaliaBarclays$7.00$5.3530.84%483.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 18, 2025Morgan StanleyUnderperformUnderperformhold
Jan 13, 2025BarclaysEqual-WeightUnderweightdowngrade
Nov 08, 2024Canaccord GenuityHoldHoldhold
Sep 17, 2024BTIGBuyinitialise
Aug 09, 2024Deutsche BankHoldHoldhold
Aug 07, 2024BarclaysEqual-WeightEqual-Weighthold
Aug 06, 2024Morgan StanleyEqual-WeightEqual-Weighthold
Aug 05, 2024Goldman SachsNeutralNeutralhold
May 09, 2024BarclaysEqual-WeightEqual-Weighthold
May 08, 2024Deutsche BankHoldHoldhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.19$-0.07$-1.79$-3.54$-1.30-
Avg Forecast$0.08$0.21$0.31$0.34$0.29$0.33
High Forecast$0.08$0.21$0.32$0.35$0.35$0.34
Low Forecast$0.08$0.20$0.29$0.29$0.21$0.32
Surprise %-337.50%-133.33%-677.42%-1141.18%-548.28%-

Revenue Forecast

$160M $179M $198M $217M $236M $255M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$166.15M$222.65M$251.41M$252.20M$241.52M-
Avg Forecast$164.50M$220.56M$251.52M$250.48M$241.16M$250.02M
High Forecast$170.12M$225.54M$251.70M$250.60M$248.91M$250.02M
Low Forecast$162.24M$218.39M$251.28M$250.31M$237.34M$250.02M
Surprise %1.01%0.95%-0.04%0.69%0.15%-

Net Income Forecast

$-450M $-350M $-250M $-150M $-50M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-51.91M$-7.22M$-202.39M$-413.12M$-138.93M-
Avg Forecast$8.87M$-34.70M$-202.39M$36.48M$31.59M$37.24M
High Forecast$9.26M$-27.76M$-161.91M$39.90M$39.62M$38.39M
Low Forecast$8.71M$-41.65M$-242.87M$33.06M$23.56M$36.09M
Surprise %-685.42%-79.19%--1232.58%-539.85%-

DH Forecast FAQ

Is Definitive Healthcare stock a buy?

Definitive Healthcare stock has a consensus rating of Hold, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 10 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Definitive Healthcare is a neutral investment for most analysts.

What is Definitive Healthcare's price target?

Definitive Healthcare's price target, set by 15 Wall Street analysts, averages $3.13 over the next 12 months. The price target range spans from $2.75 at the low end to $3.5 at the high end, suggesting a potential 160.83% change from the previous closing price of $1.2.

How does Definitive Healthcare stock forecast compare to its benchmarks?

Definitive Healthcare's stock forecast shows a 160.83% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (45.44%).

What is the breakdown of analyst ratings for Definitive Healthcare over the past three months?

  • March 2026: 0% Strong Buy, 25.00% Buy, 66.67% Hold, 0% Sell, 8.33% Strong Sell.
  • February 2026: 0% Strong Buy, 25.00% Buy, 66.67% Hold, 0% Sell, 8.33% Strong Sell.
  • January 2026: 0% Strong Buy, 23.08% Buy, 69.23% Hold, 0% Sell, 7.69% Strong Sell.

What is Definitive Healthcare’s EPS forecast?

Definitive Healthcare's average annual EPS forecast for its fiscal year ending in December 2026 is $0.33, marking a -125.38% decrease from the reported $-1.3 in 2025..

What is Definitive Healthcare’s revenue forecast?

Definitive Healthcare's average annual revenue forecast for its fiscal year ending in December 2026 is $250.02M, reflecting a 3.52% increase from the reported $241.52M in 2025.

What is Definitive Healthcare’s net income forecast?

Definitive Healthcare's net income forecast for the fiscal year ending in December 2026 stands at $37.24M, representing a -126.80% decrease from the reported $-139M in 2025.